Astrana Health plans to acquire Prospect Health System's assets for $745 million, significantly expanding its provider network and enhancing its value-based care capabilities. The deal, expected to close by mid-2025, will add approximately 610,000 members, bringing Astrana's total to over 1.7 million. With projected annual revenues of $1.2 billion from Prospect, this acquisition positions Astrana as a leading integrated care delivery platform in the U.S.
Alignment Healthcare reported a net loss of $26 million despite a 57.7% year-over-year increase in Medicare Advantage membership, reaching 182,300 members. The company raised its full-year membership and revenue guidance, projecting 184,000 to 186,000 members, while aiming for adjusted EBITDA profitability by 2025. CEO John Kao expressed confidence in achieving a $40 million adjusted EBITDA in 2025, bolstered by a five-star rating from CMS for one of its Medicare Advantage plans.
Alto Neuroscience's experimental depression drug, ALTO-100, failed to show significant improvement over a placebo in a recent trial, leading to a two-thirds drop in the company's share price. Despite this setback, analysts maintain that the company's biomarker-driven approach to drug development still holds promise, with additional data expected from other studies by 2027. Alto has sufficient funds to continue operations and explore other therapeutic avenues.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
